Oasis Diagnostics® Corporation
Biotechnology, Ne 31st Ave, Vancouver, , 98686, Washington, 15720, United States, 11-50 Employees
Who is OASIS DIAGNOSTICS® CORPORATION
Welcome to the Oasis Diagnostics LinkedIn Company Page! We're so glad you found us. Oasis Diagnostics Corporation was founded in 2002 to address a growing need for non-invasive saliva bas...
Read More
-
Headquarters: 15720 Ne 31st Ave, Vancouver, Washington, 98686, United States
-
Date Founded: 2002
-
Employees: 11-50
-
Revenue: $1 Million to $5 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 5047
Does something look wrong? Fix it. | View contact records from OASIS DIAGNOSTICS® CORPORATION
Oasis Diagnostics® Corporation Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Oasis Diagnostics® Corporation
Answer: Oasis Diagnostics® Corporation's headquarters are located at Ne 31st Ave, Vancouver, , 98686, Washington, 15720, United States
Answer: Oasis Diagnostics® Corporation's official website is https://4saliva.com
Answer: Oasis Diagnostics® Corporation's revenue is $1 Million to $5 Million
Answer: Oasis Diagnostics® Corporation's SIC: 5047
Answer: Oasis Diagnostics® Corporation has 11-50 employees
Answer: Oasis Diagnostics® Corporation is in Biotechnology
Answer: Oasis Diagnostics® Corporation contact info: Phone number: Website: https://4saliva.com
Answer: Welcome to the Oasis Diagnostics LinkedIn Company Page! We're so glad you found us. Oasis Diagnostics Corporation was founded in 2002 to address a growing need for non-invasive saliva based technology for rapid testing, sample collection, and molecular diagnostics [DNA, RNA and proteins] in the Life Sciences area. The Company is dedicated to meeting the need for more effective screening tools, which may be applied to the early detection of diseases and medical disorders, utilizing non-invasive test specimens, particularly oral fluids (saliva). The Companys range of collection and [future] diagnostic tools are covered by a portfolio of issued US, EU and International patents. Recognizing that early diagnosis is the key to disease prevention on a global basis, the Company directs its research efforts towards the development of oral based rapid, point-of-care, laboratory-based and molecular products, which fit into a Corporate objective of improving the quality of healthcare for our global customers.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month